Our leadership does not seem to have a ‘Plan B’ for Iraq, but Barr has a ‘Plan B’ for sex. They have far outperformed the lame Drug Index ETF. Management is running a good drug business.

I think we do a good job on the show explaining Barr’s business, bu it is not a stock that has any ‘sex appeal’ :) for me.

That said, it seems like a good entry is offered down at this price if you like the company. Brian offers up his view of the technicals:

Google Finance’s one pager will get you going in the right direction on more research. Your pharmacist can fill in the rest as per sales and popularity.

Disclosure – No Positions